Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion

Ansuman T. Satpathy(Stanford University), Jeffrey M. Granja(Stanford University), Kathryn E. Yost(Stanford University), Yanyan Qi(Stanford University), Francesca Meschi(10X Genomics (United States)), Geoffrey P. McDermott(10X Genomics (United States)), Brett N. Olsen(10X Genomics (United States)), Maxwell R. Mumbach(Stanford University), Sarah E. Pierce(Stanford University), M. Ryan Corces(Stanford University), Preyas Shah(10X Genomics (United States)), Jason C. Bell(10X Genomics (United States)), Darisha Jhutty(10X Genomics (United States)), Corey M. Nemec(10X Genomics (United States)), Jean Wang(10X Genomics (United States)), Li Wang(10X Genomics (United States)), Yifeng Yin(10X Genomics (United States)), Paul G. Giresi(10X Genomics (United States)), Anne Lynn S. Chang(Stanford University), Grace Zheng(10X Genomics (United States)), William J. Greenleaf(Chan Zuckerberg Initiative (United States)), Howard Y. Chang(Howard Hughes Medical Institute)
bioRxiv (Cold Spring Harbor Laboratory)
April 18, 2019
Cited by 118Open Access
Full Text

Abstract

Abstract Understanding complex tissues requires single-cell deconstruction of gene regulation with precision and scale. Here we present a massively parallel droplet-based platform for mapping transposase-accessible chromatin in tens of thousands of single cells per sample (scATAC-seq). We obtain and analyze chromatin profiles of over 200,000 single cells in two primary human systems. In blood, scATAC-seq allows marker-free identification of cell type-specific cis - and trans -regulatory elements, mapping of disease-associated enhancer activity, and reconstruction of trajectories of differentiation from progenitors to diverse and rare immune cell types. In basal cell carcinoma, scATAC-seq reveals regulatory landscapes of malignant, stromal, and immune cell types in the tumor microenvironment. Moreover, scATAC-seq of serial tumor biopsies before and after PD-1 blockade allows identification of chromatin regulators and differentiation trajectories of therapy-responsive intratumoral T cell subsets, revealing a shared regulatory program driving CD8 + T cell exhaustion and CD4 + T follicular helper cell development. We anticipate that droplet-based single-cell chromatin accessibility will provide a broadly applicable means of identifying regulatory factors and elements that underlie cell type and function.


Related Papers

No related papers found

Powered by citation graph analysis